SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report
(Date of earliest event reported):
January 21, 1997
________________________________________
THERMO INSTRUMENT SYSTEMS INC.
(Exact name of Registrant as specified in its charter)
Delaware 1-9786 04-2925809
(State or other (Commission I.R.S. Employer
jurisdiction of File Number) Identification Number)
1275 Hammerwood Avenue 94089
Sunnyvale, CA (Zip Code)
(617) 622-1000
(Registrant's telephone number
including area code)
PAGE
<PAGE>
Item 5. Other Events
On January 21, 1997, Thermo Instrument Systems Inc. (the
"Company")announced that it had commenced an all-cash tender
offer for all of the outstanding shares of Life Sciences
International PLC ("LSI"), a company listed on the London Stock
Exchange, at a price of 135 pence per share (equivalent to
approximately $2.25 per share) The Board of Directors of LSI has
recommended that its shareholders accept the offer. LSI has
approximately 175 million shares outstanding. The closing of the
transaction is subject to certain conditions, including the
tender of at least 90% of the LSI shares and antitrust regulatory
clearances in the U.S., U.K. and Germany.
Item 7. Financial Statements, Pro Forma Financial Information
and Exhibits
(c) Exhibits
99 Press Release dated January 21, 1997
PAGE
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the Registrant has duly caused this amendment to be
signed on its behalf by the undersigned thereunto duly
authorized, on this 22nd day of January. 1997.
THERMO INSTRUMENT SYSTEMS INC.
By: /s/Jonathan W. Painter
------------------------
Jonathan W. Painter
Treasurer
Exhibit 99
THERMO INSTRUMENT ANNOUNCES CASH TENDER OFFER FOR
LIFE SCIENCES INTERNATIONAL PLC
WALTHAM, Mass., January 21, 1997 -- Thermo Instrument Systems
Inc. (ASE-THI) announced today that it plans to commence a cash
tender offer for all outstanding shares of the common stock of
Life Sciences International PLC (LSI) for 135 pence per share
(equivalent to approximately $2.25 per share). LSI is a public
company in the United Kingdom headquartered in London, England,
and listed on the London Stock Exchange. The Board of Directors
of LSI has recommended that its shareholders accept the offer.
Life Sciences International PLC manufactures laboratory science
equipment, appliances, instruments, consumables, and reagents for
the research, clinical, and industrial markets. LSI is composed
of 11 major business units, with significant manufacturing and
marketing operations at various locations in the United States
and Western Europe, as well as a presence in Eastern Europe and
Asia. The company is organized into four product groups
including:
Laboratory Products - serving the global research laboratory
market with controlled- environment products, sample preparation
devices, spectrophotometers, and optical dispersion gratings;
Clinical Products - serving the hospital and clinical laboratory
markets with cell and tissue processors, mortuary equipment, and
consumables;
BioSystems - serving biotech and molecular biology R&D and QC
labs with liquid handling devices, reading systems, and
consumables; and Industrial Products - serving semiconductor
manufacturers and other industries with water baths and chillers.
"LSI has a fine reputation in the industry and promises to be an
excellent strategic fit with Thermo Instrument," said Arvin H.
Smith, president and chief executive officer of Thermo Instrument
Systems. "LSI's strong manufacturing, distribution, and service
base will help extend our product offerings into new markets,
such as clinical laboratory equipment, as well as enhance our
presence in the bio-analytical instrumentation marketplace."
There are approximately 175 million LSI shares outstanding,
giving the offer a value of approximately $395 million. Final
closure of the transaction is subject to certain conditions,
including the successful and timely completion of the public cash
tender offer yielding over 90 percent of LSI shares, and
antitrust regulatory clearances in the United States, the United
Kingdom, and Germany.
Thermo Instrument Systems Inc. develops, manufactures, and
markets instruments used to detect and measure air pollution,
radioactivity, complex chemical compounds, toxic metals, and
other elements in a broad range of liquids and solids, as well as
PAGE
<PAGE>
to control and monitor various industrial processes. Thermo
Instrument Systems is a public subsidiary of Thermo Electron
Corporation.
PAGE
<PAGE>
This press release contains forward-looking statements that
involve a number of risks and uncertainties. Important factors
that could cause actual results to differ materially from those
indicated by such forward-looking statements are set forth in
Item 5 of the company's Quarterly Report on Form 10-Q for the
quarter ended September 28, 1996. These include uncertainties
relating to competition and technological change, intellectual
property rights and litigation, dependence on certain key
industries, and international operations and risks associated
with the company's acquisition and spinout strategies.
# # #
